Vanguard reports 0 shares in Ovintiv 13G/A
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 7 to a Schedule 13G/A reporting beneficial ownership of 0 shares (0%) of Ovintiv Inc. The filing explains an internal realignment effective January 12, 2026 that disaggregated certain subsidiaries' holdings, and states that those subsidiaries now report separately in reliance on SEC Release No. 34-39538.
The amendment lists the filer’s address and certifies that no other person known to the filer holds more than 5% of the class. Signature on the form is dated March 26, 2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Vanguard report for OVV ownership in this 13G/A amendment?
Why did The Vanguard Group change how it reports Ovintiv (OVV) holdings?
Does the amendment show any Vanguard voting or dispositive power for OVV?
When was the Schedule 13G/A amendment signed for Ovintiv (OVV)?
AI-generated analysis. How Rhea-AI works. Not financial advice.